On the public citation graph

Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting

0 signed · 305 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

3 of the 180 references listed on this page are in the Retraction Watch database as retracted (export 2026-11-18): 10.1002/elsc.202200016 (notice 2025-07-14), 10.1007/s13346-020-00895-1 (notice 2023-12-05), 10.3389/fonc.2020.01756 (notice 2021-06-07).

Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/1097-0029(20001015)51:2<156::aid-jemt7>3.0.co;2-jopenalex-snapshot
Mechanism of extracellular calcium regulation of intestinal epithelial tight junction permeability: Role of cytoskeletal involvement
inferredcites →https://doi.org/10.1002/1097-0142(19940801)74:3<834::aid-cncr2820740308>3.0.co;2-9openalex-snapshot
The effects of cyclosporine on the pharmacokinetics of doxorubicin in patients with small cell lung cancer
inferredcites →https://doi.org/10.1002/bdd.628openalex-snapshot
Dose‐independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first‐pass effects to low bioavailability
inferredcites →https://doi.org/10.1002/elsc.202200016openalex-snapshot
RETRACTED: Preparation of a pH‐responsive chitosan‐montmorillonite‐nitrogen‐doped carbon quantum dots nanocarrier for attenuating doxorubicin limitations in cancer therapy
inferredcites →https://doi.org/10.1002/hep.24740openalex-snapshot
Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells
inferredcites →https://doi.org/10.1002/jcb.23210openalex-snapshot
Hyperglycemia regulates MDR-1, drug accumulation and ROS levels causing increased toxicity of carboplatin and 5-fluorouracil in MCF-7 cells
inferredcites →https://doi.org/10.1007/s00280-004-0864-4openalex-snapshot
Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093)
inferredcites →https://doi.org/10.1007/s10118-022-2775-4openalex-snapshot
Tumor-Penetrating and Mitochondria-Targeted Drug Delivery Overcomes Doxorubicin Resistance in Lung Cancer
inferredcites →https://doi.org/10.1007/s10198-006-0034-1openalex-snapshot
Comparative cost-minimisation of oral and intravenous chemotherapy for first-line treatment of non-small cell lung cancer in the UK NHS system
inferredcites →https://doi.org/10.1007/s10565-006-0140-yopenalex-snapshot
Adriamycin-induced oxidative mitochondrial cardiotoxicity
inferredcites →https://doi.org/10.1007/s10637-010-9399-1openalex-snapshot
A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction
inferredcites →https://doi.org/10.1007/s11051-020-04798-7openalex-snapshot
Transferrin-conjugated doxorubicin-loaded PLGA nanoparticles with pH-responsive behavior: a synergistic approach for cancer therapy
inferredcites →https://doi.org/10.1007/s11095-008-9763-4openalex-snapshot
Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats
inferredcites →https://doi.org/10.1007/s11095-010-0233-4openalex-snapshot
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
inferredcites →https://doi.org/10.1007/s12038-020-00065-yopenalex-snapshot
Sensitization of hepatocellular carcinoma cells towards doxorubicin and sorafenib is facilitated by glucose-dependent alterations in reactive oxygen species, P-glycoprotein and DKK4
inferredcites →https://doi.org/10.1007/s12274-020-2660-9openalex-snapshot
Stimuli-responsive combination therapy of cisplatin and Nrf2 siRNA for improving antitumor treatment of osteosarcoma
inferredcites →https://doi.org/10.1007/s13346-020-00895-1openalex-snapshot
RETRACTED ARTICLE: Co-delivery of doxorubicin and SIS3 by folate-targeted polymeric micelles for overcoming tumor multidrug resistance
inferredcites →https://doi.org/10.1007/s40005-022-00595-7openalex-snapshot
A comparative evaluation of anti-tumor activity following oral and intravenous delivery of doxorubicin in a xenograft model of breast tumor
inferredcites →https://doi.org/10.1007/s40005-022-00606-7openalex-snapshot
Pharmacokinetic modulation of substrate drugs via the inhibition of drug-metabolizing enzymes and transporters using pharmaceutical excipients
inferredcites →https://doi.org/10.1007/s41061-017-0158-zopenalex-snapshot
Potential of Casein as a Carrier for Biologically Active Agents
inferredcites →https://doi.org/10.1016/0005-2736(94)90237-2openalex-snapshot
Reversal of doxorubicin resistance and catalytic neutralization of lysosomes by a lipophilic imidazole
inferredcites →https://doi.org/10.1016/0022-2828(92)93381-sopenalex-snapshot
Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man
inferredcites →https://doi.org/10.1016/j.actbio.2015.05.010openalex-snapshot
Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells
inferredcites →https://doi.org/10.1016/j.actbio.2018.04.006openalex-snapshot
Customizing poly(lactic-co-glycolic acid) particles for biomedical applications
inferredcites →https://doi.org/10.1016/j.actbio.2021.11.050openalex-snapshot
Stimuli-responsive, dual-function prodrug encapsulated in hyaluronic acid micelles to overcome doxorubicin resistance
inferredcites →https://doi.org/10.1016/j.addr.2003.10.038openalex-snapshot
On the formulation of pH-sensitive liposomes with long circulation times
inferredcites →https://doi.org/10.1016/j.addr.2008.09.008openalex-snapshot
Barrier properties of mucus
inferredcites →https://doi.org/10.1016/j.addr.2009.05.007openalex-snapshot
Development of HPMA copolymer–anticancer conjugates: Clinical experience and lessons learnt
inferredcites →https://doi.org/10.1016/j.addr.2011.12.009openalex-snapshot
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
inferredcites →https://doi.org/10.1016/j.addr.2012.10.010openalex-snapshot
Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules
inferredcites →https://doi.org/10.1016/j.addr.2017.07.007openalex-snapshot
Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors
inferredcites →https://doi.org/10.1016/j.bbamem.2005.02.001openalex-snapshot
Stabilized plasmid–lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression
inferredcites →https://doi.org/10.1016/j.bbamem.2015.02.004openalex-snapshot
Contribution of acidic extracellular microenvironment of cancer-colonized bone to bone pain
inferredcites →https://doi.org/10.1016/j.bbrc.2016.03.002openalex-snapshot
Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway
inferredcites →https://doi.org/10.1016/j.biomaterials.2009.09.008openalex-snapshot
Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles
inferredcites →https://doi.org/10.1016/j.biomaterials.2012.06.019openalex-snapshot
Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance
inferredcites →https://doi.org/10.1016/j.biopha.2019.109323openalex-snapshot
Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model
inferredcites →https://doi.org/10.1016/j.biopha.2020.111076openalex-snapshot
Doxorubicin-loaded pH-sensitive micelles: A promising alternative to enhance antitumor activity and reduce toxicity
inferredcites →https://doi.org/10.1016/j.biopha.2021.111708openalex-snapshot
Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
inferredcites →https://doi.org/10.1016/j.bpj.2014.07.054openalex-snapshot
Real-Time Imaging of Electrical Signals with an Infrared FDA-Approved Dye
inferredcites →https://doi.org/10.1016/j.canlet.2008.11.003openalex-snapshot
Dickkopf-4 is frequently down-regulated and inhibits growth of colorectal cancer cells
inferredcites →https://doi.org/10.1016/j.carbpol.2022.120233openalex-snapshot
Linolenic acid conjugated chitosan micelles for improving the oral absorption of doxorubicin via fatty acid transporter
inferredcites →https://doi.org/10.1016/j.carbpol.2022.120390openalex-snapshot
Clay nanosheets simultaneously intercalated and stabilized by PEGylated chitosan as drug delivery vehicles for cancer chemotherapy
inferredcites →https://doi.org/10.1016/j.cclet.2022.06.006openalex-snapshot
A dual-responsive hyaluronic acid nanocomposite hydrogel drug delivery system for overcoming multiple drug resistance
inferredcites →https://doi.org/10.1016/j.cej.2021.132107openalex-snapshot
Zwitterionic polydopamine modified nanoparticles as an efficient nanoplatform to overcome both the mucus and epithelial barriers
inferredcites →https://doi.org/10.1016/j.colsurfb.2017.01.010openalex-snapshot
Transferrin gated mesoporous silica nanoparticles for redox-responsive and targeted drug delivery
inferredcites →https://doi.org/10.1016/j.cub.2013.03.043openalex-snapshot
Doxorubicin Enhances Nucleosome Turnover around Promoters
inferredcites →https://doi.org/10.1016/j.ejps.2005.08.002openalex-snapshot
In vivo tumor targeting of tumor necrosis factor-α-loaded stealth nanoparticles: Effect of MePEG molecular weight and particle size
inferredcites →https://doi.org/10.1016/j.ejps.2016.07.012openalex-snapshot
Modified-chitosan nanoparticles: Novel drug delivery systems improve oral bioavailability of doxorubicin
inferredcites →https://doi.org/10.1016/j.ejps.2016.08.035openalex-snapshot
Development of an ion-pair to improve the colon permeability of a low permeability drug: Atenolol
inferredcites →https://doi.org/10.1016/j.ejps.2017.05.038openalex-snapshot
Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy
inferredcites →https://doi.org/10.1016/j.ejps.2020.105428openalex-snapshot
Design and characterization of dual responsive mesoporous silica nanoparticles for breast cancer targeted therapy
inferredcites →https://doi.org/10.1016/j.ijbiomac.2016.10.012openalex-snapshot
Multilayer micro-dispersing system as oral carriers for co-delivery of doxorubicin hydrochloride and P-gp inhibitor
inferredcites →https://doi.org/10.1016/j.ijbiomac.2019.01.142openalex-snapshot
Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles
inferredcites →https://doi.org/10.1016/j.ijbiomac.2021.01.067openalex-snapshot
Preparation of pH-sensitive chitosan/polyvinylpyrrolidone/α-Fe2O3 nanocomposite for drug delivery application: Emphasis on ameliorating restrictions
inferredcites →https://doi.org/10.1016/j.ijpharm.2015.02.034openalex-snapshot
Large-scale manufacturing of GMP-compliant anti-EGFR targeted nanocarriers: Production of doxorubicin-loaded anti-EGFR-immunoliposomes for a first-in-man clinical trial
inferredcites →https://doi.org/10.1016/j.ijpharm.2018.11.014openalex-snapshot
Toxicological study of doxorubicin-loaded PLGA nanoparticles for the treatment of glioblastoma
inferredcites →https://doi.org/10.1016/j.ijpharm.2019.02.045openalex-snapshot
Drug nanocrystals: Fabrication methods and promising therapeutic applications
inferredcites →https://doi.org/10.1016/j.ijpharm.2019.118642openalex-snapshot
Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview
inferredcites →https://doi.org/10.1016/j.ijpharm.2019.118730openalex-snapshot
Fabrication of ultra-small nanocrystals by formation of hydrogen bonds: In vitro and in vivo evaluation
inferredcites →https://doi.org/10.1016/j.ijpharm.2019.118733openalex-snapshot
Doxorubicin-loaded PLGA nanoparticles for the chemotherapy of glioblastoma: Towards the pharmaceutical development
inferredcites →https://doi.org/10.1016/j.ijpharm.2022.121479openalex-snapshot
Oleanolic acid-conjugated human serum albumin nanoparticles encapsulating doxorubicin as synergistic combination chemotherapy in oropharyngeal carcinoma and melanoma
inferredcites →https://doi.org/10.1016/j.ijpx.2021.100089openalex-snapshot
Oral etoposide and zosuquidar bioavailability in rats: Effect of co-administration and in vitro-in vivo correlation of P-glycoprotein inhibition
inferredcites →https://doi.org/10.1016/j.jconrel.2013.02.020openalex-snapshot
Photodynamic nanomedicine in the treatment of solid tumors: Perspectives and challenges
inferredcites →https://doi.org/10.1016/j.jconrel.2015.04.003openalex-snapshot
Liposomal delivery systems for anti-cancer analogues of vitamin E
inferredcites →https://doi.org/10.1016/j.jconrel.2019.01.004openalex-snapshot
Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin
inferredcites →https://doi.org/10.1016/j.jconrel.2022.08.031openalex-snapshot
Oral administration of sodium bicarbonate can enhance the therapeutic outcome of Doxil® via neutralizing the acidic tumor microenvironment
inferredcites →https://doi.org/10.1016/j.jep.2016.12.051openalex-snapshot
Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway
inferredcites →https://doi.org/10.1016/j.lfs.2019.04.022openalex-snapshot
GRP78: A cell's response to stress
inferredcites →https://doi.org/10.1016/j.micromeso.2015.08.006openalex-snapshot
Facile synthesis of the lipid bilayer coated mesoporous silica nanocomposites and their application in drug delivery
inferredcites →https://doi.org/10.1016/j.phymed.2022.154439openalex-snapshot
Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway
inferredcites →https://doi.org/10.1016/j.reactfunctpolym.2020.104561openalex-snapshot
PEGylated N-(2 hydroxypropyl) methacrylamide-doxorubicin conjugate as pH-responsive polymeric nanoparticles for cancer therapy
inferredcites →https://doi.org/10.1016/j.taap.2018.05.037openalex-snapshot
Toxicological study of a new doxorubicin-loaded pH-sensitive liposome: A preclinical approach
inferredcites →https://doi.org/10.1016/s0006-2952(03)00467-2openalex-snapshot
Tumor acidity, ion trapping and chemotherapeutics
inferredcites →https://doi.org/10.1016/s0022-2836(65)80093-6openalex-snapshot
Diffusion of univalent ions across the lamellae of swollen phospholipids
inferredcites →https://doi.org/10.1016/s0169-409x(01)00152-1openalex-snapshot
Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics
inferredcites →https://doi.org/10.1016/s0924-8579(03)00203-6openalex-snapshot
ABC-transporters: implications on drug resistance from microorganisms to human cancers
inferredcites →https://doi.org/10.1016/s0925-4439(02)00144-8openalex-snapshot
Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis
inferredcites →https://doi.org/10.1016/s0960-9776(01)80001-1openalex-snapshot
Liposome technology and the development of Myocet™ (liposomal doxorubicin citrate)
inferredcites →https://doi.org/10.1016/s1470-2045(12)70476-xopenalex-snapshot
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
inferredcites →https://doi.org/10.1021/acs.jmedchem.7b01457openalex-snapshot
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
inferredcites →https://doi.org/10.1021/acs.jpclett.2c02272openalex-snapshot
In Vitro Binding and Release Mechanisms of Doxorubicin from Nanoclays
inferredcites →https://doi.org/10.1021/acs.molpharmaceut.6b01016openalex-snapshot
Mitochondria and Nucleus Dual Delivery System To Overcome DOX Resistance
inferredcites →https://doi.org/10.1021/acsami.6b05370openalex-snapshot
Charge-Reversal APTES-Modified Mesoporous Silica Nanoparticles with High Drug Loading and Release Controllability
inferredcites →https://doi.org/10.1021/acsomega.2c04510openalex-snapshot
Raw and Purified Clay Minerals for Drug Delivery Applications
inferredcites →https://doi.org/10.1021/ar200234qopenalex-snapshot
pH-Responsive Nanoparticles Shelled with Chitosan for Oral Delivery of Insulin: From Mechanism to Therapeutic Applications
inferredcites →https://doi.org/10.1021/mp200011fopenalex-snapshot
Augmented Anticancer Efficacy of Doxorubicin-Loaded Polymeric Nanoparticles after Oral Administration in a Breast Cancer Induced Animal Model
inferredcites →https://doi.org/10.1021/mp500833mopenalex-snapshot
Improved Oral Absorption of Doxorubicin by Amphiphilic Copolymer of Lysine-Linked Ditocopherol Polyethylene Glycol 2000 Succinate: In Vitro Characterization and in Vivo Evaluation
inferredcites →https://doi.org/10.1038/nature06396openalex-snapshot
Structural basis for gate-DNA recognition and bending by type IIA topoisomerases
inferredcites →https://doi.org/10.1038/ncomms2921openalex-snapshot
Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
inferredcites →https://doi.org/10.1038/nrc.2017.17openalex-snapshot
Prospects for combining targeted and conventional cancer therapy with immunotherapy
inferredcites →https://doi.org/10.1038/nrc2607openalex-snapshot
Targeting DNA topoisomerase II in cancer chemotherapy
inferredcites →https://doi.org/10.1038/nrc2608openalex-snapshot
DNA topoisomerase II and its growing repertoire of biological functions
inferredcites →https://doi.org/10.1038/s12276-020-0384-2openalex-snapshot
ROS in cancer therapy: the bright side of the moon
inferredcites →https://doi.org/10.1038/s41388-018-0586-4openalex-snapshot
The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers
inferredcites →https://doi.org/10.1038/s41573-018-0005-0openalex-snapshot
Polymer–drug conjugate therapeutics: advances, insights and prospects
inferredcites →https://doi.org/10.1038/s41598-022-15239-xopenalex-snapshot
Redox-sensitive doxorubicin liposome: a formulation approach for targeted tumor therapy
inferredcites →https://doi.org/10.1038/sj.bjc.6601856openalex-snapshot
Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer
inferredcites →https://doi.org/10.1038/sj.bjc.6602204openalex-snapshot
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
inferredcites →https://doi.org/10.1038/sj.bjc.6603059openalex-snapshot
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial
inferredcites →https://doi.org/10.1038/sj.bjc.6690532openalex-snapshot
Oral topotecan: bioavailability and effect of food co-administration
inferredcites →https://doi.org/10.1038/sj.gt.3302843openalex-snapshot
Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid
inferredcites →https://doi.org/10.1039/c6qm00289gopenalex-snapshot
Clinical application of polymeric micelles for the treatment of cancer
inferredcites →https://doi.org/10.1039/c9tb00212jopenalex-snapshot
Intestine-penetrating, pH-sensitive and double-layered nanoparticles for oral delivery of doxorubicin with reduced toxicity
inferredcites →https://doi.org/10.1053/ctrv.1998.0107openalex-snapshot
Clinical pharmacology of anticancer agents in relation to formulations and administration routes
inferredcites →https://doi.org/10.1054/bjoc.2000.1543openalex-snapshot
Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients
inferredcites →https://doi.org/10.1073/pnas.0807691105openalex-snapshot
Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium
inferredcites →https://doi.org/10.1073/pnas.72.7.2672openalex-snapshot
Absence of histone F1 in a mitotically dividing, genetically inactive nucleus.
inferredcites →https://doi.org/10.1073/pnas.96.8.4432openalex-snapshot
Tamoxifen inhibits acidification in cells independent of the estrogen receptor
inferredcites →https://doi.org/10.1080/10428190701190169openalex-snapshot
Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma
inferredcites →https://doi.org/10.1080/1061186x.2019.1579822openalex-snapshot
From poly(alkyl cyanoacrylate) to squalene as core material for the design of nanomedicines
inferredcites →https://doi.org/10.1080/10715762.2019.1628957openalex-snapshot
Ascorbate promotes the cellular accumulation of doxorubicin and reverses the multidrug resistance in breast cancer cells by inducing ROS-dependent ATP depletion
inferredcites →https://doi.org/10.1080/17425247.2020.1772749openalex-snapshot
Harnessing CD47 mimicry to inhibit phagocytic clearance and enhance anti-tumor efficacy of nanoliposomal doxorubicin
inferredcites →https://doi.org/10.1080/21691401.2017.1362414openalex-snapshot
Mesoporous silica nanorods for improved oral drug absorption
inferredcites →https://doi.org/10.1080/21691401.2018.1548470openalex-snapshot
Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer
inferredcites →https://doi.org/10.1088/0957-4484/22/9/095102openalex-snapshot
Improving anticancer activity and reducing systemic toxicity of doxorubicin by self-assembled polymeric micelles
inferredcites →https://doi.org/10.1093/neuonc/nou265.21openalex-snapshot
NT-23 * PHASE 1/2A STUDY OF GLUTATHIONE PEGYLATED LIPOSOMAL DOXORUBICIN (2B3-101) IN BREAST CANCER PATIENTS WITH BRAIN METASTASES (BCBM) OR RECURRENT HIGH GRADE GLIOMAS (HGG)
inferredcites →https://doi.org/10.1097/cad.0000000000000273openalex-snapshot
The interplay between GRP78 expression and Akt activation in human colon cancer cells under celecoxib treatment
inferredcites →https://doi.org/10.1111/bcp.14886openalex-snapshot
Oral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: A randomised crossover pharmacokinetic study
inferredcites →https://doi.org/10.1111/bcpt.13623openalex-snapshot
Boosting the oral bioavailability of anticancer drugs through intentional drug–drug interactions
inferredcites →https://doi.org/10.1111/cas.14373openalex-snapshot
Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR‐AKT‐mTOR signaling
inferredcites →https://doi.org/10.1126/science.1104819openalex-snapshot
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
inferredcites →https://doi.org/10.1126/science.6093249openalex-snapshot
Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II
inferredcites →https://doi.org/10.1146/annurev-physiol-021119-034627openalex-snapshot
The Acidic Tumor Microenvironment as a Driver of Cancer
inferredcites →https://doi.org/10.1158/0008-5472.can-07-5575openalex-snapshot
Bicarbonate Increases Tumor pH and Inhibits Spontaneous Metastases
inferredcites →https://doi.org/10.1158/1078-0432.ccr-06-2414openalex-snapshot
A Phase I, Randomized, Open-Label, Parallel-Cohort, Dose-Finding Study of Elacridar (GF120918) and Oral Topotecan in Cancer Patients
inferredcites →https://doi.org/10.1158/1535-7163.mct-17-0788openalex-snapshot
Photodynamic Therapy Using Indocyanine Green Loaded on Super Carbonate Apatite as Minimally Invasive Cancer Treatment
inferredcites →https://doi.org/10.1163/156856206775997322openalex-snapshot
Synthesis and characterization of PLGA nanoparticles
inferredcites →https://doi.org/10.1166/jnn.2018.16409openalex-snapshot
pH-Sensitive DOX-Loaded PAA-PF127-PAA Micelles Combined with Cryotherapy for Treating Walker 256 Carcinosarcoma in a Rat Model
inferredcites →https://doi.org/10.1172/jci45600openalex-snapshot
Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma
inferredcites →https://doi.org/10.1177/107327480301000207openalex-snapshot
Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein
inferredcites →https://doi.org/10.1186/1475-2867-13-89openalex-snapshot
Acidic extracellular microenvironment and cancer
inferredcites →https://doi.org/10.1186/2162-3619-1-10openalex-snapshot
Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis
inferredcites →https://doi.org/10.1186/s12885-019-5939-zopenalex-snapshot
Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model
inferredcites →https://doi.org/10.1186/s13046-018-0689-3openalex-snapshot
SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition
inferredcites →https://doi.org/10.1186/s13062-020-00265-4openalex-snapshot
Long non-coding RNA LINC00426 contributes to doxorubicin resistance by sponging miR-4319 in osteosarcoma
inferredcites →https://doi.org/10.1186/s13065-018-0434-1openalex-snapshot
Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles
inferredcites →https://doi.org/10.1200/jco.20.6.1668openalex-snapshot
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
inferredcites →https://doi.org/10.1200/jco.2002.12.116openalex-snapshot
Increased Oral Bioavailability of Topotecan in Combination With the Breast Cancer Resistance Protein and P-Glycoprotein Inhibitor GF120918
inferredcites →https://doi.org/10.1200/jco.2002.20.13.2918openalex-snapshot
Boosting Bioavailability of Topotecan: What Do We Gain?
inferredcites →https://doi.org/10.1200/jco.2007.14.1242openalex-snapshot
Doxorubicin, Cardiac Risk Factors, and Cardiac Toxicity in Elderly Patients With Diffuse B-Cell Non-Hodgkin's Lymphoma
inferredcites →https://doi.org/10.1211/jpp.59.4.0001openalex-snapshot
pH-Sensitive liposomes-principle and application in cancer therapy
inferredcites →https://doi.org/10.1248/bpb.b14-00508openalex-snapshot
Enhanced Oral Bioavailability of Morin Administered in Mixed Micelle Formulation with PluronicF127 and Tween80 in Rats
inferredcites →https://doi.org/10.1586/14737140.7.4.447openalex-snapshot
Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor
inferredcites →https://doi.org/10.18632/oncotarget.17559openalex-snapshot
Liposomal co-delivered oleanolic acid attenuates doxorubicin-induced multi-organ toxicity in hepatocellular carcinoma
inferredcites →https://doi.org/10.18632/oncotarget.21949openalex-snapshot
Tomentodione M sensitizes multidrug resistant cancer cells by decreasing P-glycoprotein via inhibition of p38 MAPK signaling
inferredcites →https://doi.org/10.2147/ott.s221228openalex-snapshot
Tanshinone IIA Reverses Gefitinib-Resistance In Human Non-Small-Cell Lung Cancer Via Regulation Of VEGFR/Akt Pathway
inferredcites →https://doi.org/10.2165/00002018-200124120-00004openalex-snapshot
A Comparison of Liposomal Formulations of Doxorubicin with Drug Administered in Free Form
inferredcites →https://doi.org/10.2165/00003088-198815010-00002openalex-snapshot
Clinical Pharmacokinetics of Doxorubicin
inferredcites →https://doi.org/10.2165/00003088-200443070-00002openalex-snapshot
Pharmacokinetic Optimisation of Treatment with Oral Etoposide
inferredcites →https://doi.org/10.2174/0929867013373994openalex-snapshot
Role of Apoptosis and Apoptosis-Related Genes in Cellular Response and Antitumor Efficacy of Anthracyclines
inferredcites →https://doi.org/10.2174/092986709788186228openalex-snapshot
New Developments in Anthracycline-Induced Cardiotoxicity
inferredcites →https://doi.org/10.2174/1871520621666201229115612openalex-snapshot
The Synthesis of Nano-Doxorubicin and its Anticancer Effect
inferredcites →https://doi.org/10.3109/00498254.2012.751140openalex-snapshot
The limited intestinal absorption via paracellular pathway is responsible for the low oral bioavailability of doxorubicin
inferredcites →https://doi.org/10.3109/1061186x.2012.757769openalex-snapshot
Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier
inferredcites →https://doi.org/10.3109/1061186x.2015.1051049openalex-snapshot
Nanocarriers for cancer-targeted drug delivery
inferredcites →https://doi.org/10.3109/10717544.2012.690005openalex-snapshot
Preparation and evaluation of folate-modified cationic Pluronic micelles for poorly soluble anticancer drug
inferredcites →https://doi.org/10.3389/fbioe.2022.990145openalex-snapshot
Hyaluronic acid-based nano drug delivery systems for breast cancer treatment: Recent advances
inferredcites →https://doi.org/10.3389/fonc.2020.01756openalex-snapshot
RETRACTED: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
inferredcites →https://doi.org/10.3389/fphar.2020.00567openalex-snapshot
Sulforaphane Potentiates Anticancer Effects of Doxorubicin and Cisplatin and Mitigates Their Toxic Effects
inferredcites →https://doi.org/10.3390/antiox10030349openalex-snapshot
Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery
inferredcites →https://doi.org/10.3390/biom9030098openalex-snapshot
The Main Metabolites of Fluorouracil + Adriamycin + Cyclophosphamide (FAC) Are Not Major Contributors to FAC Toxicity in H9c2 Cardiac Differentiated Cells
inferredcites →https://doi.org/10.3390/cancers13030400openalex-snapshot
Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: An Overview
inferredcites →https://doi.org/10.3390/ijms21093233openalex-snapshot
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
inferredcites →https://doi.org/10.3390/ijms23084249openalex-snapshot
Nanoliposomes in Cancer Therapy: Marketed Products and Current Clinical Trials
inferredcites →https://doi.org/10.3390/ma15113893openalex-snapshot
Nanotechnology in the Diagnostic and Therapy of Hepatocellular Carcinoma
inferredcites →https://doi.org/10.3390/molecules26051280openalex-snapshot
Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment
inferredcites →https://doi.org/10.3390/pharmaceutics12030268openalex-snapshot
Comparative Pharmacokinetics and Pharmacodynamics of a Novel Sodium-Glucose Cotransporter 2 Inhibitor, DWP16001, with Dapagliflozin and Ipragliflozin
inferredcites →https://doi.org/10.3390/pharmaceutics12090882openalex-snapshot
Enhanced Intestinal Absorption and Pharmacokinetic Modulation of Berberine and Its Metabolites through the Inhibition of P-Glycoprotein and Intestinal Metabolism in Rats Using a Berberine Mixed Micelle Formulation
inferredcites →https://doi.org/10.3390/pharmaceutics13071103openalex-snapshot
Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability
inferredcites →https://doi.org/10.3390/pharmaceutics13122181openalex-snapshot
PEGylated Liposomes Remotely Loaded with the Combination of Doxorubicin, Quinine, and Indocyanine Green Enable Successful Treatment of Multidrug-Resistant Tumors
inferredcites →https://doi.org/10.3727/096504018x15372657298381openalex-snapshot
NOTCH3 Overexpression and Posttranscriptional Regulation by miR-150 Were Associated With EGFR‐TKI Resistance in Lung Adenocarcinoma
inferredcites →https://doi.org/10.3762/bjnano.10.166openalex-snapshot
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
inferredcites →https://doi.org/10.3802/jgo.2021.32.e9openalex-snapshot
Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m2 versus 40 mg/m2 in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial
inferredcites →https://doi.org/10.3892/ijo_00000293openalex-snapshot
Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer
inferredcites →https://doi.org/10.3892/mmr.2018.8942openalex-snapshot
Chemoresistance‑related long non‑coding RNA expression profiles in human breast cancer cells
inferredcites →https://doi.org/10.3892/mmr.2019.10003openalex-snapshot
[Erratum] Chemoresistance‑related long non‑coding RNA expression profiles in human breast cancer cells
inferredcites →https://doi.org/10.3892/or.19.1.257openalex-snapshot
Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer
inferredcites →https://doi.org/10.4062/biomolther.2016.145openalex-snapshot
Involvement of NRF2 Signaling in Doxorubicin Resistance of Cancer Stem Cell-Enriched Colonospheres
inferredcites →https://doi.org/10.4103/0973-1482.139267openalex-snapshot
An overview of doxorubicin formulations in cancer therapy

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4856703openalex-extracted
Towards the Preparation of Smart Drug Delivery Platforms for Colorectal Cancer Therapy: Biocompatible and Targeted Mesoporous Silica Nanoparticles with Deferiprone-Copper Complex Gatekeeper
inferred← citeshttps://doi.org/10.2139/ssrn.5066556openalex-extracted
Simplified Maxwell-Boltzmann-Hansch Function (SMBH function) and its Application in PROTAC
inferred← citeshttps://doi.org/10.1002/adfm.202315940openalex-snapshot
Tumor‐On‐A‐Chip Model Incorporating Human‐Based Hydrogels for Easy Assessment of Metastatic Tumor Inter‐Heterogeneity
inferred← citeshttps://doi.org/10.1002/adtp.202500085openalex-snapshot
Oral Doxorubicin Lipid Nanoparticles Enhance Triple‐Negative Breast Cancer Therapy via Immune Activation and Reduced Cardiotoxicity
inferred← citeshttps://doi.org/10.1002/agt2.480openalex-snapshot
A panoramic perspective of recent progress in 2D and 3D covalent organic frameworks for drug delivery
inferred← citeshttps://doi.org/10.1002/aoc.70143openalex-snapshot
A Multifunctional Fe‐Based Metal–Organic Framework With Ferroptosis for Synergistic Therapy
inferred← citeshttps://doi.org/10.1002/ddr.22196openalex-snapshot
Apigenin alleviates doxorubicin‐induced myocardial pyroptosis by inhibiting glycogen synthase kinase‐3β in vitro and in vivo
inferred← citeshttps://doi.org/10.1002/ddr.22253openalex-snapshot
Starch‐based “smart” nanomicelles: Potential delivery systems for doxorubicin
inferred← citeshttps://doi.org/10.1002/ddr.70269openalex-snapshot
A LAT1‐Compatible, Leadlike Tyrosine‐Naphthoquinone Conjugate With Anticancer Activity
inferred← citeshttps://doi.org/10.1002/marc.70360openalex-snapshot
Photocontrolled Drug Release From Donor–Acceptor Stenhouse Adduct Amphiphile Doped Laden Polymeric Hydrogel
inferred← citeshttps://doi.org/10.1007/978-981-95-0938-6_2openalex-snapshot
Functional Nanohybrids for Solid Tumor Theranostics
inferred← citeshttps://doi.org/10.1007/978-981-95-0938-6_7openalex-snapshot
Clinical Validations of Localized Cancer Nanomedicine
inferred← citeshttps://doi.org/10.1007/978-981-95-3698-6_2openalex-snapshot
In Silico Pharmacokinetic Analysis of Topical Administration of Liposomal Nano-Drug across Different Human Skin Types: A Compartmental Numerical Approach
inferred← citeshttps://doi.org/10.1007/s00289-023-05099-4openalex-snapshot
Exploring the potential use of natural polymers to enhance the performance of MXene/MOF-5 nanocarrier in loading and co-loading of doxorubicin and curcumin
inferred← citeshttps://doi.org/10.1007/s10853-026-13684-xopenalex-snapshot
Dual-loaded nanogels and micelles for the synergistic immunomodulation of doxorubicin and resveratrol in J774.2 macrophages
inferred← citeshttps://doi.org/10.1007/s10904-024-03173-6openalex-snapshot
Polydopamine-Coated Zn-MOF-74 Nanocarriers: Versatile Drug Delivery Systems with Enhanced Biocompatibility and Cancer Therapeutic Efficacy
inferred← citeshttps://doi.org/10.1007/s12257-024-00064-yopenalex-snapshot
Bioanalysis of ursodeoxycholic acid and its metabolites and improved oral bioavailability using mixed micelles with poloxamer 407 and polysorbate 80
inferred← citeshttps://doi.org/10.1007/s13346-024-01648-0openalex-snapshot
A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer
inferred← citeshttps://doi.org/10.1007/s44174-025-00416-zopenalex-snapshot
Cubosomes as Versatile Nanocarriers: Insights into Composition, Mechanisms, and Therapeutic Applications
inferred← citeshttps://doi.org/10.1016/b978-0-323-95363-4.00004-3openalex-snapshot
Cyclodextrins in drug delivery systems
inferred← citeshttps://doi.org/10.1016/b978-0-443-22257-3.00017-9openalex-snapshot
Affordable and accessible nanomedicines: Ensuring right to health
inferred← citeshttps://doi.org/10.1016/b978-0-443-36532-4.00005-5openalex-snapshot
Nanomedicine regulatory and ethical aspects: Global perspectives and strategies
inferred← citeshttps://doi.org/10.1016/b978-0-443-43826-4.00001-4openalex-snapshot
Microneedles: An emerging approach for management of breast cancer
inferred← citeshttps://doi.org/10.1016/j.aej.2025.12.064openalex-snapshot
Nanotechnology-driven targeted therapies for gastrointestinal diseases: State-of-the-art strategies and future directions
inferred← citeshttps://doi.org/10.1016/j.bbagen.2023.130542openalex-snapshot
METTL3/IGF2BP3-regulated m6A modification of HYOU1 confers doxorubicin resistance in breast cancer
inferred← citeshttps://doi.org/10.1016/j.bbcan.2023.188965openalex-snapshot
Perspectives and mechanisms for targeting mitotic catastrophe in cancer treatment
inferred← citeshttps://doi.org/10.1016/j.bbcan.2025.189318openalex-snapshot
Comprehensive insights of etiological drivers of hepatocellular carcinoma: Fostering targeted nano delivery to anti-cancer regimes
inferred← citeshttps://doi.org/10.1016/j.bbcan.2025.189514openalex-snapshot
Organoids as a new approach in advancing cancer therapies for hematologic malignancies
inferred← citeshttps://doi.org/10.1016/j.btre.2025.e00913openalex-snapshot
Green nanoscience for healthcare: Advancing biomedical innovation through eco-synthesized nanoparticle
inferred← citeshttps://doi.org/10.1016/j.canlet.2023.216397openalex-snapshot
Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment
inferred← citeshttps://doi.org/10.1016/j.carbpol.2026.125345openalex-snapshot
Exosome-camouflaged chitosan/zinc oxide/carbon quantum dot nanocarriers for pH-responsive doxorubicin delivery in breast cancer treatment
inferred← citeshttps://doi.org/10.1016/j.carpta.2025.100677openalex-snapshot
Cyclodextrin-based nanocarriers as promising scaffolds for overcoming challenges of doxorubicin delivery in cancer chemotherapy
inferred← citeshttps://doi.org/10.1016/j.celbio.2026.100409openalex-snapshot
Metabolic programming promotes cellular uptake of extracellular vesicles and boosts in vivo therapeutic efficacy
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2025.115205openalex-snapshot
Synergistic enhancement of ferroptosis via a multi-functional metal-coordinated nanoplatform for cancer therapy
inferred← citeshttps://doi.org/10.1016/j.cpcardiol.2024.102782openalex-snapshot
Mechanisms of myocardial toxicity of antitumor drugs and potential therapeutic strategies: A review of the literature
inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.117961openalex-snapshot
Peptide inhibitors: Breaking cancer code
inferred← citeshttps://doi.org/10.1016/j.etap.2026.105147openalex-snapshot
Stage-dependent doxorubicin toxicity impairs C2C12 myogenesis via AMPK/AKT-FOXO signaling and is attenuated by metformin
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.135894openalex-snapshot
A thermo-responsive chemically crosslinked long-term-release chitosan hydrogel system increases the efficiency of synergy chemo-immunotherapy in treating brain tumors
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.145499openalex-snapshot
Recent progress in polymeric nano-structures in photo-chemotherapy and hyperthermia therapy for triple-negative breast cancer treatment: A review
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.145874openalex-snapshot
Doxorubicin loaded salicylic acid crosslinked chitosan nanoparticles as postsurgical implants for breast cancer
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.146011openalex-snapshot
Chitosan-based nanomaterials: Pioneering a review in veterinary medicine applications
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2026.154244openalex-snapshot
Co-delivery of doxorubicin and silybin via taurine-conjugated chitosan-modified TAUT-targeted liposomes enhances oral bioavailability and alleviates doxorubicin-induced cardiomyocyte toxicity in vitro
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2025.125556openalex-snapshot
Recent doxorubicin-conjugates in cancer drug delivery: Exploring conjugation strategies for enhanced efficacy and reduced toxicity
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2025.125799openalex-snapshot
Probiotic-derived microcarriers enhance the oral bioavailability of poorly absorbed anticancer drugs
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2026.127540openalex-snapshot
Erythrocyte-membrane camouflaged manganese dioxide-polydopamine nanocarriers for doxorubicin delivery and MRI-visualized chemo-photothermal cancer therapy
inferred← citeshttps://doi.org/10.1016/j.ijpx.2025.100353openalex-snapshot
Nanoparticle technologies in precision oncology and personalized vaccine development: Challenges and advances
inferred← citeshttps://doi.org/10.1016/j.jconrel.2024.11.004openalex-snapshot
Revisiting nanomedicine design strategies for follow-on products: A model-informed approach to optimize performance
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.106020openalex-snapshot
Efflux transporter inhibitory (EXTRIN) micelles for enhanced ocular drug delivery
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.106087openalex-snapshot
Towards the preparation of smart drug delivery platforms for colorectal cancer therapy: Biocompatible and targeted mesoporous silica nanoparticles with the deferiprone-copper complex gatekeeper
inferred← citeshttps://doi.org/10.1016/j.jddst.2025.106969openalex-snapshot
Development of pimozide spray dried lipid nanoparticles with enhanced targeting of non-small cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.jddst.2025.106980openalex-snapshot
Marine L-arginase encapsulated in poly (lactic-co-glycolic acid) nanoparticles: A novel anti-cancer strategy for effective hepatocellular carcinoma treatment in vitro and in vivo
inferred← citeshttps://doi.org/10.1016/j.jddst.2025.107839openalex-snapshot
Taguchi–machine learning hybrid framework for optimization of particulate drug delivery systems
inferred← citeshttps://doi.org/10.1016/j.jpba.2025.117012openalex-snapshot
Mapping the polar metabolome in Huh-7 liver cancer cells reveal the role of atorvastatin in enhancing chemotherapeutic efficacy of doxorubicin
inferred← citeshttps://doi.org/10.1016/j.jtice.2025.105992openalex-snapshot
Hydrolysis-assisted synthesis of magnetic iron oxide-silica/poly(methacrylic acid) nanocomposites for pH- and thermo-responsive doxorubicin delivery
inferred← citeshttps://doi.org/10.1016/j.metop.2025.100440openalex-snapshot
Protective effects of medicinal honey against doxorubicin-induced hepatorenal toxicity in rats: A novel grading index (PAD score) based on phenolic content and antioxidant capacity
inferred← citeshttps://doi.org/10.1016/j.mtbio.2025.102263openalex-snapshot
Transferrin receptor 1-targeted polymersomes therapy for colorectal cancer
inferred← citeshttps://doi.org/10.1016/j.reprotox.2025.109082openalex-snapshot
Allicin attenuates doxorubicin-induced testicular and systemic toxicity in rats via antioxidant and anti-apoptotic mechanisms
inferred← citeshttps://doi.org/10.1016/j.rsurfi.2025.100473openalex-snapshot
From bench to bedside: Advancing liposomal doxorubicin for targeted cancer therapy
inferred← citeshttps://doi.org/10.1016/j.xkme.2025.100998openalex-snapshot
Acute Kidney Injury Secondary to Pegylated Liposomal Doxorubicin-Associated Renal-limited Thrombotic Microangiopathy
inferred← citeshttps://doi.org/10.1016/j.xphs.2025.103853openalex-snapshot
Enhancing the bioavailability and targeting of etoposide as a potential small cell Lung Cancer treatment
inferred← citeshttps://doi.org/10.1021/acs.jcim.3c01973openalex-snapshot
Empowering Graph Neural Networks with Block-Based Dual Adaptive Deep Adjustment for Drug Resistance-Related NcRNA Discovery
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.6c00129openalex-snapshot
Done EAZY: An Automated Procedure for 89Zr-Radiolabeling and Size-Exclusion Chromatography Purification of Nanoliposomal Anticancer Therapeutics
inferred← citeshttps://doi.org/10.1021/acsabm.4c00552openalex-snapshot
Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines
inferred← citeshttps://doi.org/10.1021/acsabm.4c01092openalex-snapshot
Biosynthesis of pH-Responsive Mesoporous Silica Nanoparticles from Cucumber Peels for Targeting 3D Lung Tumor Spheroids
inferred← citeshttps://doi.org/10.1021/acsabm.4c01364openalex-snapshot
Peptide-Based Prodrug Approaches for Cancer Nanomedicine
inferred← citeshttps://doi.org/10.1021/acsanm.3c04519openalex-snapshot
Hydroxyapatite Nanocrystals Integrated into Mesoporous Silica for Sustained Delivery of Doxorubicin
inferred← citeshttps://doi.org/10.1021/acsapm.5c01389openalex-snapshot
Hyaluronic Acid Nanocapsules as pH-Responsive Nanocarriers for Controlled Doxorubicin Delivery
inferred← citeshttps://doi.org/10.1021/acsomega.5c06730openalex-snapshot
Mechanistic Insights into the Anticancer Action of Novel 2-Hydroxy-1,4-naphthoquinone Thiol Derivatives
inferred← citeshttps://doi.org/10.1038/s41598-026-58290-8openalex-snapshot
Alkaline loading of extracellular vesicles produced from human neural stem cell-derived neurospheres enables CNS drug delivery
inferred← citeshttps://doi.org/10.1039/d5pm00090dopenalex-snapshot
Advances in targeted therapies and emerging strategies for blood cancer treatment
inferred← citeshttps://doi.org/10.1039/d6md00084copenalex-snapshot
Beyond infection control: exploring the therapeutic potential of antimicrobials in oncology and their synthetic perspectives
inferred← citeshttps://doi.org/10.1039/d6na00107fopenalex-snapshot
Beta-cyclodextrin-based polymerized nanocarriers for doxorubicin delivery to cancer cells
inferred← citeshttps://doi.org/10.1039/d6nh00103copenalex-snapshot
Nanocapsules as smart natural product drug delivery systems: recent advances and future directions
inferred← citeshttps://doi.org/10.1063/5.0275809openalex-snapshot
Three-dimensional finite element modelling of chemical environment in droplet-based microfluidic systems for drug therapy applications
inferred← citeshttps://doi.org/10.1080/00914037.2025.2610712openalex-snapshot
Folate-functionalized chitosan nanoparticles: a versatile platform for targeted drug delivery and biomedical applications
inferred← citeshttps://doi.org/10.1080/03639045.2026.2703044openalex-snapshot
Rutin-enabled improved systemic exposure of doxorubicin via nanostructured lipid carriers: a proof of concept through novel LC-MS/MS analysis
inferred← citeshttps://doi.org/10.1080/1061186x.2025.2467139openalex-snapshot
Role of liposomes in chemoimmunotherapy of breast cancer
inferred← citeshttps://doi.org/10.1080/10717544.2024.2439272openalex-snapshot
Incorporation of doxorubicin into plant-derived nanovesicles: process monitoring and activity assessment
inferred← citeshttps://doi.org/10.1080/14737140.2025.2604621openalex-snapshot
Liposomal nanomedicine in cancer therapy: advances in drug delivery
inferred← citeshttps://doi.org/10.1080/17435889.2024.2350357openalex-snapshot
Integrin receptor-targeted, doxorubicin-loaded cerium oxide nanoparticles delivery to combat glioblastoma
inferred← citeshttps://doi.org/10.1080/17435889.2026.2637591openalex-snapshot
Nanotechnology based targeted drug delivery systems for breast cancer: challenges, recent advancement and future perspectives
inferred← citeshttps://doi.org/10.1080/25740881.2024.2440531openalex-snapshot
“Innovative Polymers in Pharmaceutical Chemistry: Revolutionizing Drug Delivery Systems”
inferred← citeshttps://doi.org/10.1101/2025.01.04.631287openalex-snapshot
Targeting and combating drug resistance in triple-negative breast cancer using nano polymer: Efficacy of A6 peptide-PLGA-PEG nanoparticle loaded with doxorubicin and anti-miR-21 in in vitro and vivo model
inferred← citeshttps://doi.org/10.1101/2025.02.24.639871openalex-snapshot
Transferrin Receptor 1-targeted polymersomes therapy for Colorectal Cancer
inferred← citeshttps://doi.org/10.1111/bph.70085openalex-snapshot
Dexrazoxane protects against doxorubicin‐induced cardiotoxicity in susceptible human living myocardial slices: A proof‐of‐concept study
inferred← citeshttps://doi.org/10.1186/s12896-026-01122-4openalex-snapshot
Nanoparticles co-loaded with bacillus Calmette-Guérin pure protein derivative and doxorubicin for bladder tumor therapy
inferred← citeshttps://doi.org/10.1186/s12986-026-01094-4openalex-snapshot
Natural bioactive molecules and chemotherapeutics synergism for enhanced cancer therapy
inferred← citeshttps://doi.org/10.1208/s12248-026-01318-8openalex-snapshot
Nanocarrier-Enabled Delivery of Glucosinolates for Skin Cancer Prevention and Therapy
inferred← citeshttps://doi.org/10.15212/bioi-2024-0107openalex-snapshot
Lipid-based Nanoparticles: Strategy for Targeted Cancer Therapy
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3841276/v1openalex-snapshot
Analysis of Chemotherapy Regimens on Survival Rate of Breast Cancer Patients
inferred← citeshttps://doi.org/10.2147/bctt.s501448openalex-snapshot
From Pioneering Discoveries to Innovative Therapies: A Journey Through the History and Advancements of Nanoparticles in Breast Cancer Treatment
inferred← citeshttps://doi.org/10.2147/ijn.s568254openalex-snapshot
Nanotechnology-Driven Cancer Therapies for Precision Oncology: Advances and Clinical Outlook
inferred← citeshttps://doi.org/10.2174/0113816128319233240725103706openalex-snapshot
Advancements in Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Breast Cancer Therapy
inferred← citeshttps://doi.org/10.2174/0113894501384020250804093144openalex-snapshot
Development of Novel Intravesical Formulation for Bladder Retention Targeting Bladder Disorders
inferred← citeshttps://doi.org/10.2174/0115748928394153250731033624openalex-snapshot
ABC Transporter Protein-mediated Multidrug Resistance in Breast Cancer and Development of Targeting Strategies
inferred← citeshttps://doi.org/10.2174/0116695410403506250830211556openalex-snapshot
Vesicular Assemblies of Non-ionic Surfactants Niosomes: Design, Preparation, and Applications in Drug Delivery
inferred← citeshttps://doi.org/10.2174/0126673878312411240703085013openalex-snapshot
Advancements in Micellar Formulation: Drug Delivery Vehicle for Water-Insoluble Drugs
inferred← citeshttps://doi.org/10.2174/0126673878366151250815012551openalex-snapshot
Polymeric Nanocarriers with pH-Dependent Release for Tumor-Specific Delivery
inferred← citeshttps://doi.org/10.2174/9798898810276125010010openalex-snapshot
Understanding Quinones with Reference to Biochemistry
inferred← citeshttps://doi.org/10.22159/ijap.2025v17i6.54533openalex-snapshot
ENHANCED COMBINED EFFECTS OF GARCINIA COWA BARK EXTRACT AND DOXORUBICIN ON CELL CYCLE REGULATION AND P53 EXPRESSION IN T47D BREAST CANCER CELLS
inferred← citeshttps://doi.org/10.2217/nnm-2023-0196openalex-snapshot
An Update Review of Smart Nanotherapeutics and Liver Cancer: Opportunities and Challenges
inferred← citeshttps://doi.org/10.3389/fmolb.2024.1494257openalex-snapshot
Protein-free domains in native and ferroptosis-driven oxidized cell membranes: a molecular dynamics study of biophysical properties and doxorubicin uptake
inferred← citeshttps://doi.org/10.3390/biom16010137openalex-snapshot
Magnetic Nanocarriers with ICPTES- and GPTMS-Functionalized Quaternary Chitosan for pH-Responsive Doxorubicin Release
inferred← citeshttps://doi.org/10.3390/biomedicines14040757openalex-snapshot
Benzyl-Naphthoquinones as Selective Anticancer Agents for Oral Squamous Cell Carcinoma via Apoptosis Induction
inferred← citeshttps://doi.org/10.3390/cancers17142303openalex-snapshot
Advances in Doxorubicin Chemotherapy: Emerging Polymeric Nanocarriers for Drug Loading and Delivery
inferred← citeshttps://doi.org/10.3390/cells13110924openalex-snapshot
Apoptosis, a Metabolic “Head-to-Head” between Tumor and T Cells: Implications for Immunotherapy
inferred← citeshttps://doi.org/10.3390/cells14181471openalex-snapshot
Temporal Dynamics of Extracellular Matrix Remodeling in Anthracycline-Induced Cardiotoxicity
inferred← citeshttps://doi.org/10.3390/cimb48060636openalex-snapshot
In Vitro Evaluation of Combination Therapy with Doxorubicin and Quercetin for Uveal Melanoma
inferred← citeshttps://doi.org/10.3390/ijms25020945openalex-snapshot
Chloroquine and Chemotherapeutic Compounds in Experimental Cancer Treatment
inferred← citeshttps://doi.org/10.3390/ijms25031375openalex-snapshot
Ligand-Based Design of Selective Peptidomimetic uPA and TMPRSS2 Inhibitors with Arg Bioisosteres
inferred← citeshttps://doi.org/10.3390/ijms26093966openalex-snapshot
Understanding the Mechanisms of Chemotherapy-Related Cardiotoxicity Employing hiPSC-Derived Cardiomyocyte Models for Drug Screening and the Identification of Genetic and Epigenetic Variants
inferred← citeshttps://doi.org/10.3390/molecules30030676openalex-snapshot
Comprehensive Methodology for Evaluating the Drug Loading of Iron Oxide Nanoparticles Using Combined Magnetometry and Mössbauer Spectroscopy
inferred← citeshttps://doi.org/10.3390/molecules31030557openalex-snapshot
Ginsenoside Rg5 Targets PRDX1 to Disrupt Redox Homeostasis and Induce Mitochondria-Dependent Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells
inferred← citeshttps://doi.org/10.3390/ph16101336openalex-snapshot
Feature Reviews in Pharmaceutical Technology
inferred← citeshttps://doi.org/10.3390/ph18091244openalex-snapshot
Phytocannabinoids and Nanotechnology in Lung Cancer: A Review of Therapeutic Strategies with a Focus on Halloysite Nanotubes
inferred← citeshttps://doi.org/10.3390/pharmaceutics16050650openalex-snapshot
Effect of Tight Junction-Modulating FCIGRL-Modified Peptides on the Intestinal Absorption of Doxorubicin in Rats
inferred← citeshttps://doi.org/10.3390/pharmaceutics16060739openalex-snapshot
Hybrid Nanosystem Formed by DOX-Loaded Liposomes and Extracellular Vesicles from MDA-MB-231 Is Effective against Breast Cancer Cells with Different Molecular Profiles
inferred← citeshttps://doi.org/10.3390/pharmaceutics17020202openalex-snapshot
Preparing a Liposome-Aided Drug Delivery System: The Entrapment and Release Profiles of Doxorubicin and 9-(N-Piperazinyl)-5-methyl-12(H)-quino [3,4-b][1,4]benzothiazinium Chloride with Human Serum Albumin
inferred← citeshttps://doi.org/10.3390/pharmaceutics17060779openalex-snapshot
Surfactant-Enabled Nanocarriers in Breast Cancer Therapy: Targeted Delivery and Multidrug Resistance Reversal
inferred← citeshttps://doi.org/10.34172/bi.30848openalex-snapshot
Enhanced efficacy of breast cancer treatment with etoposide-graphene oxide nanogels: A novel nanomedicine approach
inferred← citeshttps://doi.org/10.34172/jhp.2026.53139openalex-snapshot
Cytotoxicity activity and in silico studies from ethanol, ethyl acetate, and n-hexane extracts of Marchantia paleacea liverwort herb on MCF-7 and T47D breast cancer cells
inferred← citeshttps://doi.org/10.4236/anp.2024.133004openalex-snapshot
Charcoal Nanoparticles as a Delivery System for Doxorubicin and Sorafenib in Treatment of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.51435/turkjac.1433347openalex-snapshot
Validation of High-Performance Liquid Chromatography method for the determination of doxorubicin in proliposomal drug delivery system formulation
inferred← citeshttps://doi.org/10.5772/intechopen.1007334openalex-snapshot
Innovations in Drug Delivery Strategies for Breast Cancer
inferred← citeshttps://doi.org/10.6023/a25020034openalex-snapshot
Two Step Synthesis of Octreotide-doxorubicin Conjugates Based on Disulfide Bond Linker
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.